Insurance businesses may help HFCs unlock value for investors: Deven Choksey, K R Choksey Securities"It appears that we should remain in 8250 to 8750 kind of a range for Nifty for at least some more time until more factors emerge."
Fall in crude prices positive for OMCs: Deven Choksey, KR Choksey SecuritiesI would think that a fall in crude prices is advantageous before the traders, says Choksey. This gives an opportunity to buy OMCs, he adds.
See more upside in Reliance stock going forward: Deven Choksey, K R Choksey SecuritiesI am waiting for the data to come out probably on the petrochemical side as well. My own take is that the company has also enjoyed better m...
Don't sell Rolta India in a hurry, wait for more clarity: Deven ChokseyChoksey says that one should not sell the stock till the time, he/she gets fully convinced that the company made genuine accounting errors.
Don’t expect banking space to do that well in Q4: Deven Choksey, K R Choksey SecuritiesI would not call it a complete disappointment, but yes, we are likely to see some amount of let-down in certain pockets. For example, in th...
Select commodity stocks look good on valuation: Deven Choksey"At this point of time, I do believe that at least select commodity stocks certainly demands consideration in adding into the portfolio."
RIL Q2 profit up 2.6%: What experts sayReliance Industries posted a better-than-expected net profit at Rs 5,490 crore for the quarter ended September, up 2.6 per cent.
Still in a range-bound market, remain cautious: Deven Choksey, KR Choksey SecuritiesMy belief is that we are still in a range-bound market, we still probably struggle around to cross 6300 plus levels out, says Deven Choksey.
- See valuations of many mid-cap companies becoming very attractive: Deven Choksey, K R Choksey Securities
In an interview with ET Now, Deven Choksey, MD, K R Choksey Securities, gives his views on the market. Excerpts:
- Marico restructuring plan to unlock value
Marico's management has proposed restructuring of the company into two separate companies - FMCG company and Kaya Skin.
- Buy Reliance on declines: K R Choksey Securities
Any fall in the stock price could become once again a buy opportunity for global investors to begin with and then local investors thereafte...
- Ranbaxy, Cipla and Glenmark may go up by 20-25% in longer term: K R Choksey Securities
Ranbaxy, Cipla and Glenmark kind of companies would have a scope to go up by around 20% to 25% again in next 12 to 18 months time from now.
- Markets have already factored in disappointing IIP numbers: Deven Choksey
You may see some better news going forward from the western markets, particularly from USA, says Deven Choksey, MD, K R Choksey Securities.
- Buy in midcap and small cap space: Deven Choksey
Deven Choksey, MD, K R Choksey Securities in a chat with ET Now gives his take on midcap and small cap space.
- 25% appreciation expected in ICICI Bank: Deven Choksey
Deven Choksey, MD, K R Choksey Securities in a chat with ET Now gives his outlook on ICICI Bank.
- Bajaj Finserv is a long term play: Deven Choksey
Deven Choksey, MD, K R Choksey Securities in a chat with ET Now gives his outlook on Bajaj Auto, Maruti Suzuki and Bajaj Finserv.
- Never time entry into the market: K R Choksey Shares and Securities
For a long term investor, valuations in stocks like SBI, BHEL, Infosys and RIL are attractive and one could look at buying these.